Back to Search
Start Over
A cost‐effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first‐line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan.
- Source :
- Cancer Reports; Oct2023, Vol. 6 Issue 10, p1-13, 13p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 25738348
- Volume :
- 6
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Cancer Reports
- Publication Type :
- Academic Journal
- Accession number :
- 173182670
- Full Text :
- https://doi.org/10.1002/cnr2.1887